Anthony is SVP, Head of Research at a Stealth NewCo and an experienced drug hunter having contributed to multiple clinical compounds including three approved medicines. Previously, Anthony was Head of Immunology at Kymera where he was responsible for building an outstanding immunology team and portfolio of heterobifunctional protein degraders for the treatment of autoimmune disorders. He has held leadership positions in Immunology at AbbVie and Boehringer Ingelheim, and scientific roles at The Genomics Institute of the Novartis Research Foundation and Amgen, previously Tularik. Anthony received his BSc. (Hons) and PhD from The University of Melbourne and completed his training with Fellowships at Harvard Medical School and Stanford University.